跳至主要内容
临床试验/PACTR202308810518432
PACTR202308810518432招募中4 期

Open-Label, Randomized Controlled Study Comparing The Efficacy And Tolerability Of Artemether-Lumefantrine And Artesunate-Amodiaquine In Hiv Patients With Kidney Disease Treated With Dolutegravir-Based Antiretroviral Therapy

Dr. Abdulwasiu A Busari0 个研究点目标入组 120 人开始时间: 2023年8月18日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • 1. Age 18 years and older.
  • 2. HIV positive
  • 3. Fever (axillary temperature = 37.5°C), or history of fever in previous 48 hours;
  • 4. Microscopic confirmation of asexual stages of P. falciparum or mixed infection or malaria parasite densities >2,000/?l
  • 5. Receiving ART for at least 3 months.
  • 6. Having CKD as evident by GFR <60 mL/min/1.73m2 and/or proteinuria
  • 7. Willingness to give informed consent.

排除标准

  • 1. Pregnancy.
  • 2. Severe/complicated malaria.
  • 3.Severe anaemia (<8.5 g/dl haemoglobin (Hb));
  • 4. Full course of AA or AL treatment or more than two doses of another antimalarial in the past four weeks.
  • 5. Known hypersensitivity to artemisinin derivates, amodiaquine, artemether-lumefantrine, or raltegravir.
  • 6. Patient on haemodialysis
  • 7. Patient with a history of cardiac arrhythmias
  • 8. Not willing to give informed consent

研究者

发起方
Dr. Abdulwasiu A Busari

相似试验

进行中(未招募)
1 期
Clinical study aimed to compare tocilizumab to anti-TNF treatment and to discover biomarkers for treatment selection in rheumatoid arthritis patients with inadequate response to a first anti-TNFRHEUMATOID ARTHRITISMedDRA version: 20.0Level: LLTClassification code 10037738Term: R arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 23.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 20.0Level: LLTClassification code 10039014Term: Rh arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 23.1Level: LLTClassification code 10003268Term: Arthritis rheumatoidSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
EUCTR2016-001987-12-ITSOCIETA' ITALIANA DI REUMATOLOGIA - SIR208
招募中
3 期
A study to examine whether giving steroids in low dose daily is more effective than if given on alternate days, in controlling disease activity in patients with frequently relapsing nephrotic syndrome
CTRI/2019/01/017091Indian Council of Medical Research
招募中
4 期
A study to compare efficacy of daily prednisolone versus standard alternate day prednisolone in patients with frequently relapsing nephrotic syndrome.
CTRI/2012/12/003194Council of Scientific and Industrial Research60
已完成
3 期
A comparative clinical study to evaluate efficacy and safety of fixed dose combination of Ceftriaxone + Sulbactam (CSE 1034) vs Ceftriaxone in patients suffering from various bacterial infections
CTRI/2010/091/000174Venus Remedies Limited654
已完成
2 期
Comparative study to evaluate the Effectiveness of GanjhuVirTM a herbal antiviral in Cases of Dengue Fever with Thrombocytopenia
CTRI/2019/01/017096Radhika Ayurveda Research and Development